Balance-sheet HealthResolute's materially reduced leverage (debt ≈A$312M; D/E ≈0.30) and improved equity position provide durable financial flexibility. A stronger balance sheet lowers refinancing and solvency risk during commodity cycles, enabling funding for projects and smoothing capital allocation over the next 2–6 months.
Cash GenerationSignificant operating cash flow and positive free cash flow in 2025 materially improve funding capacity for sustaining and growth capex without immediate reliance on equity. Strong cash generation increases resilience to volatility and supports near-term project funding and potential deleveraging, despite historical variability.
Transformative Growth Project (Doropo)The Doropo DFS outlines a long-life, low-AISC (DFS LOM $1,406/oz) project with strong NPV and IRR metrics; if executed, it materially expands production and free cash flow over a multi-year horizon. This project-driven growth potential is a durable strategic lever for margin and reserve longevity.